These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4987126)

  • 21. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; McLean AA; Hilleman MR
    Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of live attenuated varicella vaccine (Oka-RIT strain) and combined varicella and MMR vaccination in 13-17-month-old children.
    Vesikari T; Ohrling A; Baer M; Delem A; Bogaerts H; André FE
    Acta Paediatr Scand; 1991 Nov; 80(11):1051-7. PubMed ID: 1661057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rubella vaccination using Cendehill's live virus vaccine].
    Vivell O; Merschmann E; Lips G; Reiss G
    Arch Kinderheilkd; 1969 Sep; 179(3):259-66. PubMed ID: 5350790
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children.
    Watson BM; Laufer DS; Kuter BJ; Staehle B; White CJ; Starr SE
    J Infect Dis; 1996 Mar; 173(3):731-4. PubMed ID: 8627041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; Stokes J; Hilleman MR
    Pediatrics; 1973 Mar; 51(3):467-75. PubMed ID: 4707864
    [No Abstract]   [Full Text] [Related]  

  • 26. Viral shedding in Chinese children following vaccination with HPV-77 and Cendehill-51 live attenuated rubella vaccines.
    Detels R; Kim KS; Gale JL; Grayston JT
    Am J Epidemiol; 1971 Nov; 94(5):473-8. PubMed ID: 4941155
    [No Abstract]   [Full Text] [Related]  

  • 27. [German measles. (II). German measles vaccine].
    Miyata T
    Nihon Shonika Gakkai Zasshi; 1969 Nov; 73(11):1868-73. PubMed ID: 5393380
    [No Abstract]   [Full Text] [Related]  

  • 28. A trial with live attenuated rubella vaccine.
    Lepow ML; Veronelli JA; Hostetler DD; Robbins FC
    Am J Dis Child; 1968 Jun; 115(6):639-47. PubMed ID: 4968320
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies with rubella vaccine (RA 27-3) using the subcutaneous and intranasal routes.
    Moffat MA; Gould JJ; Forbes FA; Freestone DS; Macdonald A
    Scott Med J; 1972 Apr; 17(4):140-2. PubMed ID: 4554067
    [No Abstract]   [Full Text] [Related]  

  • 30. Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group.
    White CJ; Stinson D; Staehle B; Cho I; Matthews H; Ngai A; Keller P; Eiden J; Kuter B
    Clin Infect Dis; 1997 May; 24(5):925-31. PubMed ID: 9142794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical trial of live attenuated rubella virus vaccine, HPV-77 strain.
    Cooper LZ; Giles JP; Krugman S
    Am J Dis Child; 1968 Jun; 115(6):655-7. PubMed ID: 4968322
    [No Abstract]   [Full Text] [Related]  

  • 32. [Immunization of healthy children with measles-mumps-rubella trivalent vaccine simultaneously given with varicella vaccine].
    Takayama N; Kidokoro M; Suzuki K; Morita M
    Kansenshogaku Zasshi; 1992 Jun; 66(6):776-80. PubMed ID: 1331262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A comparative evaluation of the immunogenic activity of attenuated strains of rubella virus from the USA, Belgium and the USSR].
    Nifontova AI; Meshalova VN; Iakovleva NV; Smorodintsev AA
    Vopr Virusol; 1970; 15(6):711-4. PubMed ID: 5518646
    [No Abstract]   [Full Text] [Related]  

  • 34. An open community trial of live rubella vaccines. Study of vaccine virus transmissibility and antigenic efficacy of three HPV-77 derivatives.
    Veronelli JA
    JAMA; 1970 Sep; 213(11):1829-36. PubMed ID: 4917635
    [No Abstract]   [Full Text] [Related]  

  • 35. Further studies of an attenuated rubella strain grown in WI-38 cells.
    Plotkin SA; Farquhar JD; Katz M; Hertz C
    Am J Epidemiol; 1969 Feb; 89(2):232-8. PubMed ID: 5765961
    [No Abstract]   [Full Text] [Related]  

  • 36. Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies.
    Stokes J; Weibel RE; Villarejos VM; Arguedas JA; Buynak EB; Hilleman MR
    JAMA; 1971 Oct; 218(1):57-61. PubMed ID: 4937795
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experience with vaccination with attenuated rubella vaccine (strain HPV-77 adapted to duck cells, 5th passage)].
    Rocchi G; Salvadori A
    Nuovi Ann Ig Microbiol; 1970; 21(4):336-40. PubMed ID: 5518412
    [No Abstract]   [Full Text] [Related]  

  • 38. Attenuated rubella virus vaccines in children with tuberculosis. Clinical trials.
    Boué A; Celers J
    Am J Dis Child; 1969 Aug; 118(2):258-60. PubMed ID: 4893827
    [No Abstract]   [Full Text] [Related]  

  • 39. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of immunity following live mumps (5 years), measles (3 years), and rubella (2 and one-half years) virus vaccines.
    Weibel RE; Buynak EB; Stokes J; Hilleman MR
    Pediatrics; 1972 Mar; 49(3):334-41. PubMed ID: 5010464
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.